Precipio (NASDAQ:PRPO) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened

Precipio, Inc. (NASDAQ:PRPO) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.41 and traded as high as $7.46. Precipio shares last traded at $7.23, with a volume of 2,318 shares trading hands.

Precipio Price Performance

The firm has a 50 day simple moving average of $6.65 and a 200-day simple moving average of $6.41. The company has a quick ratio of 0.60, a current ratio of 0.73 and a debt-to-equity ratio of 0.02. The company has a market cap of $10.72 million, a PE ratio of -3.95 and a beta of 1.42.

Institutional Investors Weigh In On Precipio

An institutional investor recently bought a new position in Precipio stock. Renaissance Technologies LLC purchased a new position in Precipio, Inc. (NASDAQ:PRPO) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,100 shares of the biotechnology company’s stock, valued at approximately $56,000. Renaissance Technologies LLC owned approximately 0.68% of Precipio as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 10.45% of the company’s stock.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.